These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 192629

  • 1. [The excretion of chorionic gonadetropin in 55 cases of hydatidiform mole (author's transl)].
    Lichtenegger W, Weiss PA.
    Geburtshilfe Frauenheilkd; 1977 Apr; 37(4):334-7. PubMed ID: 192629
    [Abstract] [Full Text] [Related]

  • 2. [Biological and biochemical properties of human chorionic gonadotropin from urine of patients with hydatidiform mole and its radioimmunoassay (author's transl)].
    Nishimura R, Hamamoto T, Tanabe K, Takemori M, Ashitaka Y, Tojo S.
    Nihon Naibunpi Gakkai Zasshi; 1981 Nov 20; 57(11):1632-44. PubMed ID: 7327293
    [Abstract] [Full Text] [Related]

  • 3. Gonadotropin and steroid hormone excretion in trophoblastic neoplasia.
    Ishizuka N, Okamoto M, Tomoda Y.
    Obstet Gynecol; 1973 Jul 20; 42(1):1-11. PubMed ID: 4352641
    [No Abstract] [Full Text] [Related]

  • 4. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
    Kanda K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct 20; 32(10):1575-82. PubMed ID: 6263995
    [Abstract] [Full Text] [Related]

  • 5. Dissociation of chorioadenoma destruens from hydatidiform mole by urinary steroid analysis.
    Kodama M, Kodama T, Totani R.
    Am J Obstet Gynecol; 1981 Oct 01; 141(3):288-93. PubMed ID: 6269431
    [Abstract] [Full Text] [Related]

  • 6. Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve.
    van Cromvoirt SM, Thomas CM, Quinn MA, McNally OM, Bekkers RL.
    Gynecol Oncol; 2014 Jun 01; 133(3):542-5. PubMed ID: 24631700
    [Abstract] [Full Text] [Related]

  • 7. Steroid profiles in hydatidiform mole associated with theca-lutein cysts.
    Vanluchene E, Thiery M, Dhont M, Vandekerchkhove D.
    Z Geburtshilfe Perinatol; 1977 Aug 01; 181(4):294-7. PubMed ID: 906612
    [Abstract] [Full Text] [Related]

  • 8. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
    Tscherne G, Pürstner P.
    Geburtshilfe Frauenheilkd; 1979 Aug 01; 39(8):704-8. PubMed ID: 478273
    [Abstract] [Full Text] [Related]

  • 9. [Vesicular mole with slight elimination of HCG in a clinical series from 1964 to the present].
    Cappelli N, Giorgi G, Teti G.
    Minerva Ginecol; 1977 Nov 01; 29(11):802. PubMed ID: 609381
    [No Abstract] [Full Text] [Related]

  • 10. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR, Risse EK, Kenemans P, Houx PC, Stolk JG, Vooijs GP.
    Obstet Gynecol; 1983 Oct 01; 62(4):467-73. PubMed ID: 6888825
    [Abstract] [Full Text] [Related]

  • 11. [Detection of hCG production in trophoblastic diseases by HCG beta carboxyl-terminal peptide].
    Shimizu T, Matsuura S, Mochizuki M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Oct 01; 35(10):1759-66. PubMed ID: 6195275
    [Abstract] [Full Text] [Related]

  • 12. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY, Yen GL.
    Chin Med J (Engl); 1991 Dec 01; 104(12):995-8. PubMed ID: 1723674
    [Abstract] [Full Text] [Related]

  • 13. [On the results of hydatidiform mole managed by Niigata method].
    Hando T, Kodama S, Takeuchi S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec 01; 37(12):2722-30. PubMed ID: 4086902
    [Abstract] [Full Text] [Related]

  • 14. [On the follow up period of postmolar patient (author's transl)].
    Hando T, Maruyama S, Watanabe S, Hirogami T, Obata N, Kanazawa K, Takeuchi S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Mar 01; 34(3):287-91. PubMed ID: 7069243
    [Abstract] [Full Text] [Related]

  • 15. Partial hydatidiform mole with false-negative urine human chorionic gonadatropin test in the emergency department.
    Mundangepfupfu T, Waseem M.
    J Emerg Med; 2014 Mar 01; 46(3):348-50. PubMed ID: 24188605
    [Abstract] [Full Text] [Related]

  • 16. [Urinary gonadotropin fragment measurement in the monitoring of trophoblastic disease].
    Fu CY, Cole LA, Kardana A.
    Zhonghua Fu Chan Ke Za Zhi; 1994 Aug 01; 29(8):475-7, 510-1. PubMed ID: 7835119
    [Abstract] [Full Text] [Related]

  • 17. Serum relaxin in patients with hydatidiform mole.
    Seki K, Uesato T, Tabei T, Kato K.
    Obstet Gynecol; 1986 Mar 01; 67(3):381-3. PubMed ID: 3945450
    [Abstract] [Full Text] [Related]

  • 18. [Study on follow-up procedure for postmolar patients].
    Endo N, Kobayashi O, Takamizawa H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Apr 01; 36(4):531-8. PubMed ID: 6715935
    [Abstract] [Full Text] [Related]

  • 19. [Urinary hCG excretion patterns of patients with chorionic tumor during chemotherapy: indication of remission by chemotherapy].
    Isojima S, Koyama K, Kamata T, Naka O, Kushiki N.
    Nihon Naibunpi Gakkai Zasshi; 1973 Dec 20; 49(12):1424-35. PubMed ID: 4359526
    [No Abstract] [Full Text] [Related]

  • 20. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M.
    Aust N Z J Obstet Gynaecol; 2006 Apr 20; 46(2):119-23. PubMed ID: 16638033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.